검색어 : 통합검색[KIEC]
총 610건 중 610건 출력
, 56/61 페이지
-
551
- Induction of nitric oxide synthase (NOS) and vascular endothelial growth factor (VEGF) in experimental model of angioplasty and heart ischemia.
- Dembinska-Kiec, A; Dulak, J; Partyka, L; Krzesz, R; Dudek, D; Bartus, S; Polus, M; Guevara, I; Wybranska, I; Krzeminski, T; ; (Advances in experimental medicine and biology, v.433, 1997, pp.163-167)
-
552
- Natural selenium particles from Staphylococcus carnosus: Hazards or particles with particular promise?
- Estevam, E.C.; Griffin, S.; Nasim, M.J.; Denezhkin, P.; Schneider, R.; Lilischkis, R.; Dominguez-Alvarez, E.; Witek, K.; Latacz, G.; Keck, C.; Schafer, K.H.; Kiec-Kononowicz, K.; Handzlik, J.; Jacob, C.; ; (Journal of hazardous materials, v.324, 2017, pp.22-30)
-
553
- Influence of LDL-apheresis on vascular endothelial growth factor (VEGF<SUB>165</SUB>), von Willebrand Factor (vWF) and β thromboglobulin (β-TG) levels in patients after PTCA or CABG
- Dembinska-Kiec, A.; Piwowarska, W.; Sinzinger, H.; Bartus, S.; Konduracka, E.; Golabek, I.; Hartwich, J.; Zdzeniecka, A.; Guevara, I.; Dudek, D.; ; (International Dresden Lipid Symposium, v.1998, 1998, pp.131-136)
-
554
- Prostaglandins and fibroblast functions in vitro.
- Schö nhö fer, P S; Rü cker, W; Dembinska-Kiec, A; Peters, H D; Peskar, B A; von Figura, K; ; (Agents and actions supplements : AAS, v.5, 1979, pp.39-51)
-
555
- P1.069 Genetic spectrum of dopa-responsive dystonia in the Polish families
- Rudzinska, M.; Bodzioch, M.; Lapicka-Bodzioch, K.; Zapał a, B.; Potulska-Chromik, A.; Janik, P.; Jamrozik, Z.; Dembinska-Kiec, A.; Szczudlik, A.; ; (Parkinsonism & related disorders, v.15, 2009, pp.S46-S46)
-
556
- Human adipose tissue stromal vascular fraction cells differentiate depending on distinct types of media
- Balwierz, A.; Czech, U.; Polus, A.; Filipkowski, R. K.; Mioduszewska, B.; Proszynski, T.; Kolodziejczyk, P.; Skrzeczynska-Moncznik, J.; Dudek, W.; Kaczmarek, L.; Kulig, J.; Pryjma, J.; Dembinska-Kiec, A.; Department Clinical Biochemistry Collegium Medicum, Jagiellonian University, Krakow, Poland,; Department Clinical Biochemistry Collegium Medicum, Jagiellonian University, Krakow, Poland,; Department Clinical Biochemistry Collegium Medicum, Jagiellonian University, Krakow, Poland,; Department Molecular and Cellular Neurobiology, Laboratory of Molecular Neurobiology, Nencki Institute, Warsaw, Poland,; Department Molecular and Cellular Neurobiology, Laboratory of Molecular Neurobiology, Nencki Institute, Warsaw, Poland,; Department Molecular and Cellular Neurobiology, Laboratory of Molecular Neurobiology, Nencki Institute, Warsaw, Poland,; 1st Department General and GI Surgery Collegium Medicum, Jagiellonian University Krakow, Poland,; Department Immunology, Faculty of Biotechnology, Jagiellonian University, Krakow, Poland,; Department of Gynecology and Obstetrics, District Hospital, Myslenice, Poland, and; Department Molecular and Cellular Neurobiology, Laboratory of Molecular N; (Cell proliferation, v.41, 2008, pp.441-459)
-
557
- A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus
- Hohendorff, J.; Szopa, M.; Skupien, J.; Kapusta, M.; Zapala, B.; Platek, T.; Mrozinska, S.; Parpan, T.; Glodzik, W.; Ludwig-Galezowska, A.; Kiec-Wilk, B.; Klupa, T.; Malecki, M. T.; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland; Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland; Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland; Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland; Brothers Hospitallers’ of St. John of God Hospital, Krakow, Poland; Sanatio Medical Center, Krakow, Poland; Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland; Department of Metabolic Diseases, Jagiellonian U; (Endocrine, v.57, 2017, pp.272-279)
-
558
- Rational design in search for 5-phenylhydantoin selective 5-HT<sub>7</sub>R antagonists. Molecular modeling, synthesis and biological evaluation
- Kucwaj-Brysz, K.; Warszycki, D.; Podlewska, S.; Witek, J.; Witek, K.; Gonzalez Izquierdo, A.; Satala, G.; Loza, M.I.; Lubelska, A.; Latacz, G.; Bojarski, A.J.; Castro, M.; Kiec-Kononowicz, K.; Handzlik, J.; ; (European journal of medicinal chemistry, v.112, 2016, pp.258-269)
-
559
- Platelet activation and endothelial factors in standard exercise test before and after menopause
- Krzysiek, J.; Milewicz, T.; Dybkowski, R.; Janczak-Saif, A.; Dembinska-Kiec, A.; Zdzienicka, A.; Guevara, I.; Sztefko, K.; Radkowicki, S.; Dubiel, J. S.; ; (Przeglad lekarski : organ Towarzystwa Lekarskiego Krakowskiego, Oddziału, PTL, v.58, 2001, pp.419-425)
-
560
- Nitric Oxide Induces the Synthesis of Vascular Endothelial Growth Factor by Rat Vascular Smooth Muscle Cells
- Dulak, Jó zef; Jó zkowicz, Alicja; Dembinska-Kiec, Aldona; Guevara, Ibeth; Zdzienicka, Anna; Zmudzinska-Grochot, Danuta; Florek, Izabela; Wó jtowicz, Anna; Szuba, Andrzej; Cooke, John P.; From the Department of Clinical Biochemistry (J.D., A.D-K., A.J., I.G., A.Z., D.Z-G., I.F., A.W.), Collegium Medicum, Jagiellonian University, Krakó w, Poland; and the Falk Cardiovascular Research Center (A.S., J.P.C.), Stanford University, Stanford, Calif.; From the Department of Clinical Biochemistry (J.D., A.D-K., A.J., I.G., A.Z., D.Z-G., I.F., A.W.), Collegium Medicum, Jagiellonian University, Krakó w, Poland; and the Falk Cardiovascular Research Center (A.S., J.P.C.), Stanford University, Stanford, Calif.; From the Department of Clinical Biochemistry (J.D., A.D-K., A.J., I.G., A.Z., D.Z-G., I.F., A.W.), Collegium Medicum, Jagiellonian University, Krakó w, Poland; and the Falk Cardiovascular Research Center (A.S., J.P.C.), Stanford University, Stanford, Calif.; From the Department of Clinical Biochemistry (J.D., A.D-K., A.J., I.G., A.Z., D.Z-G., I.F., A.W.), Collegium Medicum, Jagiellonian University, Krakó w, Poland; and the Falk Cardiovascular Research; (Arteriosclerosis, thrombosis, and vascular biology, v.20, 2000, pp.659-666)
QUICK MENU
